A phase II and pharmacological study of weekly oral paclitaxel (Paxoral (R)) plus cyclosporin A (CsA) in patients with advanced non-smal cell lung cancer (NSCLC)

C.M.F. Kruijtzer, J.H.M. Schellens, J. Mezger, M.E. Scheulen, U. Keilholz, J.H. Beijnen, H. Rosing, R.A.A. Mathot, S. Marcus, H. van Tinteren, P. Baas

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)4508-4516
Number of pages8
JournalJournal of Clinical Oncology
Volume20
Publication statusPublished - 2002

Cite this